BioWorld

Aug. 6, 2010

Analysis SORTs Out Blood Lipids, Heart Disease Risk

NewCo News: Sweden's BioChromix Pharma Tackles AD's Amyloid Cascade

Alexza Slides on $18M Stock Offering, PDUFA Date Ahead

Alexza Pharmaceuticals Inc. is raising $18 million in a registered direct offering of stock and warrants, news that sent shares of the Mountain View, Calif.-based firm falling 18 percent Thursday. (BioWorld Today) Read More

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Today's news in brief

BioWorld

BioWorld briefs for April 2, 2026.

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

Amlogenyx’s AM-805 reduces amyloid plaques in AD

BioWorld Science

The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...